Sick leave and factors influencing sick leave in adult patients with atopic dermatitis: A cross-sectional study

Journal of Clinical Medicine

Volumn 4, Issue 4, 2015, Pages 535-547

  van Os Medendorp, Harmieke ^a   Appelman Noordermeer, Simone ^a   Bruijnzeel Koomen, Carla ^a   de Bruin Weller, Marjolein ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atopic dermatitis; Influencing factors; Quality of life; Severity; Sick leave; Socio occupational factors

Indexed keywords

ADULT; ALLERGY; ARTICLE; ATOPIC DERMATITIS; AVOIDANCE BEHAVIOR; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DISTRESS SYNDROME; EDUCATIONAL STATUS; FEMALE; HUMAN; JOB SATISFACTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PREVALENCE; QUALITY OF LIFE;

EID: 85019341670     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm4040535     Document Type: Article

References (29)

1. Eichenfield, L.F.; Tom, W.L.; Chamlin, S.L.; Feldman, S.R.; Hanifin, J.M.; Simpson, E.L.; Berger, T.G.; Bergman, J.N.; Cohen, D.E.; Cooper, K.D., et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J. Am. Acad. Dermatol. 2014, 70, 338–351.
2. Verboom, P.; Hakkaart-Van, L.; Sturkenboom, M.; de Zeeuw, R.; Menke, H.; Rutten, F. The cost of atopic dermatitis in the Netherlands: An international comparison. Br. J. Dermatol. 2002, 147, 716–724.
3. Holm, E.A.; Esmann, S.; Jemec, G.B. The handicap caused by atopic dermatitis—Sick leave and job avoidance. J. Eur. Acad. Dermatol. Venereol. 2006, 20, 255–259.
4. Zuberbier, T.; Orlow, S.J.; Paller, A.S.; Taieb, A.; Allen, R.; Hernanz-Hermosa, J.M.; Ocampo-Candiani, J.; Cox, M.; Langeraar, J.; Simon, J.C. Patient perspectives on the management of atopic dermatitis. J. Allergy Clin. Immunol. 2006, 118, 226–232.
5. Torrelo, A.; Ortiz, J.; Alomar, A.; Ros, S.; Prieto, M.; Cuervo, J. Atopic dermatitis: Impact on quality of life and patients’ attitudes toward its management. Eur. J. Dermatol. 2012, 22, 97–105.
6. Fowler, J.F.; Duh, M.S.; Rovba, L.; Buteau, S.; Pinheiro, L.; Lobo, F.; Sung, J.; Doyle, J.J.; Swensen, A.; Mallett, D.A., et al. The direct and indirect cost burden of atopic dermatitis: An employer-payer perspective. Manag. Care Interface 2007, 20, 26–32.
7. Barbeau, M.; Bpharm, H.L. Burden of Atopic dermatitis in Canada. Int. J. Dermatol. 2006, 45, 31–36.
8. Gonzalez Barcala, F.J.; la Fuente-Cid, R.D.; Alvarez-Gil, R.; Tafalla, M.; Nuevo, J.; Caamano-Isorna, F. Factors associated with a higher prevalence of work disability among asthmatic patients. J. Asthma 2011, 48, 194–199.
9. Boot, C.R.; van der Gulden, J.W.; Orbon, K.H.; Vercoulen, J.H.; Akkermans, R.; van Weel, C.; Folgering, H.T. Asthma and chronic obstructive pulmonary disease: Differences between workers with and without sick leave. Int. Arch. Occup. Environ. Health 2004, 77, 357–362.
10. Schmitt, J.M.; Ford, D.E. Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology 2006, 213, 102–110.
11. Boot, C.R.; Vercoulen, J.H.; van der Gulden, J.W.; van den Borne, B.H.; Orbon, K.H.; van Weel, C.; Folgering, H.T. Sick leave in workers with asthma and COPD: The role of attitudes, perceived social norms and self efficacy. Patient Educ. Couns. 2005, 58, 192–198.
12. Accordini, S.; Bugiani, M.; Arossa, W.; Gerzeli, S.; Marinoni, A.; Olivieri, M.; Pirina, P.; Carrozzi, L.; Dallari, R.; de Togni, A., et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int. Arch. Allergy Immunol. 2006, 141, 189–198.
13. Boot, C.R.; Vercoulen, J.H.; van der Gulden, J.W.; Orbon, K.H.; Rooijackers, J.M.; van Weel, C.; Folgering, H.T. Predictors of changes in sick leave in workers with asthma: A follow-up study. Int. Arch. Occup. Environ. Health 2005, 78, 633–640.
14. TNO. Ziekteverzuim in Nederland in 2010. Available online: http://www.rijksoverheid.nl/documenten-en-publicaties/brochures/2012/03/19/ziekteverzuim-in-nederland-in-2010.html (accessed on 1 May 2014)
15. Mann, C.J. Observational research methods. Research design II: Cohort, cross sectional, and case-control studies. Emerg. Med. J. 2003, 20, 54–60.
16. Roelen, C.A.; Koopmans, P.C.; Groothoff, J.W. Subjective health complaints in relation to sickness absence. Work 2010, 37, 15–21.
17. Poulsen, O.M.; Persson, R.; Kristiansen, J.; Andersen, L.L.; Villadsen, E.; Orbaek, P. Distribution of subjective health complaints, and their association with register based sickness absence in the Danish working population. Scand. J. Public Health 2013, 41, 150–157.
18. Charman, C.R.; Venn, A.J.; Ravenscroft, J.C.; Williams, H.C. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods. Br. J. Dermatol. 2013, 169, 1326–1332.
19. Vendrig, A. A Vragenlijst Arbeidsreintegratie. Available online: http://vendrig.praktijkinfo.nl/pagina/33/materialen-var/ (accessed on 1 May 2013).
20. Vendrig, L. Risico op langdurig verzuim onderzocht met de Vragenlijst ArbeidsReïntegratie (VAR). Tijdschr. Gezondh. 2007, 85, 386–391.
21. Vendrig, L. De vragenlijst arbeidsreintegratie. Diagn. Wijzer 2005, 8, 27–39.
22. Chren, M.M.; Lasek, R.J.; Quinn, L.M.; Mostow, E.N.; Zyzanski, S.J. Skindex, a quality-of-life measure for patients with skin disease: Reliability, validity, and responsiveness. J. Investig. Dermatol. 1996, 107, 707–713.
23. Prinsen, C.A.; Lindeboom, R.; Sprangers, M.A.; Legierse, C.M.; de Korte, J. Health-related quality of life assessment in dermatology: Interpretation of Skindex-29 scores using patient-based anchors. J. Investig. Dermatol. 2010, 130, 1318–1322.
24. Stichting Aquamarijn Handleiding Nederlandstalige Skindex-29; Een dermatologiespecifieke kwaliteit-van-leven vragenlijst. Available online: http://www.scribd.com/doc/1186801/skindex-handleiding (accessed on 1 May 2013).
25. Chren, M.M.; Lasek, R.J.; Flocke, S.A.; Zyzanski, S.J. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch. Dermatol. 1997, 133, 1433–1440.
26. Chren, M.M. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol. Clin. 2012, 30, 231–236.
27. Charman, C.R.; Venn, A.J.; Williams, H.C. The patient-oriented eczema measure: Development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch. Dermatol. 2004, 140, 1513–1519.
28. Schram, M.E.; Spuls, P.I.; Leeflang, M.M.; Lindeboom, R.; Bos, J.D.; Schmitt, J. EASI, (objective) SCORAD and POEM for atopic eczema: Responsiveness and minimal clinically important difference. Allergy 2012, 67, 99–106.
29. Raosoft Sample size calculator, 2004. Available online: http://www.raosoft.com/samplesize.html (accessed on 1 January 2012).